Ultrastaging of sentinel lymph nodes (SLNs) vs. non-SLNs in colorectal cancer—do we need both? - 19/08/11
Corresponding author. Tel.: 810-230-9600; fax: 810-230-9607Abstract |
Background |
The aim of this study to analyze whether ultrastaging of initially negative nonsentinel lymph nodes (non-SLNs) would increase nodal positivity in colon cancer and rectal cancer.
Methods |
After SLN mapping (SLNM), SLNs were ultrastaged by 4 hematoxylin and eosin and 1 immunohistochemistry sections. A blinded pathologist reexamined initially negative non-SLNs by 3 additional hematoxylin and eosin and 1 immunohistochemistry sections.
Results |
In 156 colon cancer and 44 rectal cancer patients, 2,755 nodes were identified (494 SLNs and 2,261 non-SLNs). Metastases were detected in 20.9% of SLNs and 8.6% of non-SLNs (P < .0001). After ultrastaging non-SLNs, only .58% became positive for metastases in 12 patients. Of these, 10 already had positive lymph nodes, hence no change of staging occurred. Ultrastaging upstaged only 2 of 200 patients (1%).
Conclusions |
The chance of finding additional metastases by ultrastaging of all non-SLNs is extremely low (<1%) and of little benefit.
Le texte complet de cet article est disponible en PDF.Keywords : Sentinel lymph node mapping, Ultrastaging, Nonsentinal lymph node, Colorectal cancer
Plan
Vol 199 - N° 3
P. 354-358 - mars 2010 Retour au numéro
Article précédent
- Follow-up disparities after trauma: a real problem for outcomes research
- William H. Leukhardt, Joseph F. Golob, Andy M. McCoy, Adam M.A. Fadlalla, Mark A. Malangoni, Jeffrey A. Claridge
- Early enteral nutrition can be successfully implemented in trauma patients with an “open abdomen”
- Matthew C. Byrnes, Patty Reicks, Eric Irwin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?